about
Performance evaluation of platelet counting by novel fluorescent dye staining in the XN-series automated hematology analyzers.Bacterial Pneumonia-induced Persistent Remission of Severe Immune Thrombocytopenia after Allogeneic Hematopoietic Stem Cell Transplantation.High concentrations of L-ascorbic acid specifically inhibit the growth of human leukemic cells via downregulation of HIF-1α transcription.Establishment of a humanized APL model via the transplantation of PML-RARA-transduced human common myeloid progenitors into immunodeficient mice.Ribosomal Biogenesis and Translational Flux Inhibition by the Selective Inhibitor of Nuclear Export (SINE) XPO1 Antagonist KPT-185.In vivo analysis of the role of aberrant histone deacetylase recruitment and RAR alpha blockade in the pathogenesis of acute promyelocytic leukemia.miR-133 regulates Evi1 expression in AML cells as a potential therapeutic targetFour hepatosplenic T-cell lymphoma cases of Japanese patients.Induction of apoptosis in myeloid leukaemic cells by ribozymes targeted against AML1/MTG8A leukemic change as an initial manifestation of the common variant type of ALK-positive anaplastic large cell lymphoma in a patient with lung adenocarcinoma.Integrative genomic and proteomic analyses identifies glycerol-3-phosphate acyltransferase as a target of low-dose ionizing radiation in EBV infected-B cells.FLT3-ITD drives Ara-C resistance in leukemic cells via the induction of RUNX3.Association of promyelocytic leukemia protein with expression of IL-6 and resistance to treatment in multiple myeloma.FLT3-ITD induces ara-C resistance in myeloid leukemic cells through the repression of the ENT1 expression.C/EBPalpha and C/EBPvarepsilon induce the monocytic differentiation of myelomonocytic cells with the MLL-chimeric fusion gene.Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report.The formation of an aberrant PAX5 transcript in a patient with mixed phenotype acute leukemia harboring der(9)t(7;9)(q11.2;p13).A novel therapeutic technology of specific RNA inhibition for acute promyelocytic leukemia: improved design of maxizymes against PML/RARalpha mRNA.Spontaneous resolution of transfusion-associated graft-versus-host disease.High event-free survival rate with minimum-dose-anthracycline treatment in childhood acute promyelocytic leukaemia: a nationwide prospective study by the Japanese Paediatric Leukaemia/Lymphoma Study Group.Retinoid resistance in leukemic cells.Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features.All-trans and 9-cis retinoic acid enhance 1,25-dihydroxyvitamin D3-induced monocytic differentiation of U937 cells.Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).Hepatosplenic T-cell lymphoma appearing in the peripheral blood.Establishment of a xenograft model of human myelodysplastic syndromesIdentification of a novel SEPT9-ABL1 fusion gene in a patient with T-cell prolymphocytic leukemia.Persistence of derivative chromosome 22 after achieving a major molecular response in chronic myeloid leukemia with a cryptic BCR-ABL1 fusion gene.[Follicular lymphoma in two brothers].A novel differentiation-inducing therapy for acute promyelocytic leukemia with a combination of arsenic trioxide and GM-CSF.Novel variant isoform of G-CSF receptor involved in induction of proliferation of FDCP-2 cells: relevance to the pathogenesis of myelodysplastic syndrome.Evaluation of the body fluid mode of automated hematology analyzer XN-series for extremely low peripheral white blood cell counts.Localized or diffuse lesions of the submandibular glands in immunoglobulin g4-related disease in association with differential organ involvement.Atypical chronic myeloid leukemia harboring NUP98-HOXA9.RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes.A novel retinoic acid receptor (RAR)-selective antagonist inhibits differentiation and apoptosis of HL-60 cells: implications of RARalpha-mediated signals in myeloid leukemic cells.Marked erythroblastosis in myelodysplastic syndrome induced by gastric hemorrhaging.The infiltration of classical Hodgkin lymphoma cells into pleural effusion.Erythrophagocytosis by blasts in acute myeloid leukaemia harbouring the BCR-ABL1 fusion gene.Clinical and pathological features of B-cell non-Hodgkin lymphomas lacking the surface expression of immunoglobulin light chains.
P50
Q33414064-544071BA-09A6-4EFC-AAA8-D6FAC911BA16Q33429322-8AA2E387-E3B0-4D96-8670-DCE3B3B5ACCBQ34693392-6D6F1F8E-B598-4DF7-B0C0-1872E2448F52Q35391634-44B25ECF-44B8-4246-9D65-22DF52A185CFQ35764599-EF0001ED-03FB-4469-A592-7EB8E69CF948Q36228502-22749681-3878-4AF7-A146-9C4BA9D4239AQ36453826-6178DD6F-0DE1-4B6E-A617-050CE37867B3Q36458231-881401C7-7770-4EDA-B73B-D8C0CE42DED7Q36619128-01C5CAA9-3FBD-4AA0-B50A-A6ACA107F2D4Q37337885-A41422B3-F74F-40F9-AE3F-CACECF2F1BFBQ38799502-9AB51247-F541-4E10-85F5-42824DDF6DA8Q38827310-FAD91582-8AA4-42A0-9312-5337A288C1EFQ39294366-13CA720A-1F60-4B2D-8506-7AD0CCEAE272Q39784014-04FDF61F-1DD3-4990-A4DD-274D3CFEFDC8Q39942216-957C7EE9-80F6-4354-AFAB-93A92C025B9CQ40475626-A5836DB9-3A62-417A-B47C-163336F0B9FEQ40475729-AF0396CA-6105-4BEE-AB07-45D1C7847306Q40672351-A9311CBE-E88D-4C80-B934-815809E00383Q40685272-C91A6316-5DD6-42AE-A1E5-DEB5AF043939Q40735293-386959A8-1857-41E5-8B52-5D03F9BEE03EQ41111400-97B407B1-6066-4E44-8A76-48DAA58CFCF8Q41172463-06653F92-0387-4FCA-8487-F519F74C576DQ41177274-529553D5-837C-4E06-8064-7B83279F0E92Q41283253-523B0BAD-1C62-426C-BA79-38A576DDBA57Q42189966-A7B8069E-A450-47A1-820D-B1F1918279EEQ42708649-9D6CF36C-1FC4-4D26-8C8F-4E8E8C70FE00Q42748652-46B053FA-73A0-4FC3-AF6B-6A0D7D547BB6Q43226802-E2AD2DF2-D6BD-42AC-9EE3-6A01A9E751C8Q43673255-D62F1615-46A0-4E78-8012-CBFFCB88EF7AQ43692571-83593684-8514-4307-BAAA-49F09B2D3CBAQ43994817-C289FCB8-78DC-4271-99B1-E3AD496E4CDCQ45359502-E751F225-30BE-4C0D-92E9-E9840DFD2EBDQ45716240-4F8AE921-9AB3-4E1D-A36B-8A6990F13BFDQ46357968-2AC17C95-EED9-4F35-8106-D79DDD558B1BQ46676669-4BF005A8-BC71-4DB5-91F2-92008C6083ABQ47788570-DA3B790C-98D7-4FB9-84CA-B1144BA98551Q48213161-2018503E-51BD-42E7-93A6-4A9FCE3102EAQ48356914-7C963437-9954-4164-916D-450A2EC98556Q50459480-F6D65B3B-DA44-4FF3-960F-E1A3666CF579Q50901350-A4C1970C-C241-499D-8DE1-70B822C0D31B
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hiromichi Matsushita
@ast
Hiromichi Matsushita
@en
Hiromichi Matsushita
@es
Hiromichi Matsushita
@nl
Hiromichi Matsushita
@sl
type
label
Hiromichi Matsushita
@ast
Hiromichi Matsushita
@en
Hiromichi Matsushita
@es
Hiromichi Matsushita
@nl
Hiromichi Matsushita
@sl
prefLabel
Hiromichi Matsushita
@ast
Hiromichi Matsushita
@en
Hiromichi Matsushita
@es
Hiromichi Matsushita
@nl
Hiromichi Matsushita
@sl
P106
P21
P31
P496
0000-0002-1629-6630
P569
2000-01-01T00:00:00Z